Curium acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy

London and Paris, Dec. 02, 2019 (GLOBE NEWSWIRE) -- a?? Curium has successfully completed the acquisition of Finnish radiopharmaceuticals company MAP Medical Technologies Oy. A The acquisition of MAP Medical will further expand Curiuma??s footprint in Europe, providing direct access to Nordic and Baltic countries for its broad portfolio of life saving diagnostic solutions.MAP Medical operates three GMP manufacturing sites across Finland, two in Helsinki and one in Tikkakoski, and has been supplying critical radiopharmaceutical agents to customers across Nordics and Baltics since 1991. The Company employs c.50 people and offers a range of PET diagnostic agents. It is also a distributor of Curiuma??s SPECT product portfolio in Finland.a??We are looking forward to integrating MAP Medical into our network of 25 PET sites across Europea?? says Benoit Woessmer, CEO of PET EUROPE at Curium. a??This acquisition complements our current geographical footprint and enables us to offer our broad range of products and future pipeline of innovative agents to customers and patients across Nordics and Baltics.a??a??The MAP Medical team is excited to be part of a global nuclear medicine platforma?? commented Mika NyyssA¶nen and Jarmo Haukka, co-founders of MAP Medical. a??We are confident that, in Curium, they have found the right home to further build their careers in this exciting field, developing and commercializing lifesaving diagnostic and therapeutic solutions to patients globallya??.###
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2020    »